Fundz

Promedius raises 21.5 billion won in funding, doubling its fundraising target, with participation from Starset Investment, Woori Venture Partners, and more.

PRIVATEJun 10, 2026

Amount Raised

₩21.5 Billion

Round Type

Pre-Seed

SeoulBiotechnologyHealth CareArtificial Intelligence

Investors

Ibk Industrial BankHeungkuk Securities Quark PeYookyung Psg Asset ManagementQuad Asset ManagementSL InvestmentKolon InvestmentNaverDaewoong PharmaceuticalWoori Venture PartnersStarset Investment

Description

Promedius recently succeeded in raising 21.5 billion won in funding, exceeding their original target. The latest round saw participation from existing and new investors, including Daewoong Pharmaceutical and Naver. Founded in 2019, Promedius is developing AI technology for early detection of aging and metabolic diseases. This funding will enhance their innovative efforts.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Promedius that raised within 45 days of this round, from Fundz verified event records.

  • TidalSense raised $19M on July 24, 2026.
  • InnoDtech raised $3.4M (Seed) on July 23, 2026.
  • Transcripta Bio raised $24M (Series A) on July 22, 2026.
  • mediworkAI raised an undisclosed amount on July 21, 2026.
  • Sightera Biosciences raised $3.4M (Pre-Seed) on July 17, 2026.
  • Neuble AI raised $269K (Seed) on July 16, 2026.

Who to call at Promedius, and when

A new round usually means Promedius is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Promedius raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Promedius, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Promedius. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Promedius

Location

Seoul, South Korea

About

Promedius is a company founded in 2019 by researchers from Asan Medical Center. It focuses on developing technology that uses artificial intelligence (AI) to detect aging and metabolic diseases at an early stage. The company's cumulative funding now exceeds 35 billion won, with the latest round raising 21.5 billion won. Promedius aims to enhance early diagnosis and intervention in age-related and metabolic health issues.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Promedius raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsHyun-Jin J., Chief Executive Officer hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Promedius's next move

See what Strategic adds

Promedius raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.